{"id":43317,"date":"2026-02-14T14:49:29","date_gmt":"2026-02-14T14:49:29","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/phage-therapy-market-mordor\/"},"modified":"2026-03-27T03:15:52","modified_gmt":"2026-03-26T18:15:52","slug":"phage-therapy-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/phage-therapy-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/phage-therapy-market-1752162824787-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/phage-therapy-market-size-image-1768492207474.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud604\ud669<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ub2e4\uc81c\ub0b4\uc131(MDR) \uac10\uc5fc\uc758 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc784\uc0c1 \ub2e8\uacc4 \ud30c\uc9c0 \ud30c\uc774\ud504\ub77c\uc778 \ubc0f \uc790\uae08 \uc870\ub2ec \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.3 \uad6d\uac00 \ud30c\uc9c0 \uc740\ud589 \ubc0f \ub3d9\uc815\uc801 \uc0ac\uc6a9 \ub124\ud2b8\uc6cc\ud06c \uad6c\ucd95<\/li>\n<li class=\"toc-level-3\">4.2.4 \ud569\uc131 \uc0dd\ubb3c\ud559 \uae30\ubc18 &#8216;\ub514\uc790\uc774\ub108&#8217; \ud30c\uc9c0\uc758 \uc784\uc0c1 \uc9c4\uc785<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud30c\uc9c0 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \uc2e0\uc18d \uc2ec\uc0ac \uc9c0\uc815<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc815\ubc00 \ub9c8\uc774\ud06c\ub85c\ubc14\uc774\uc634 \uc758\ud559 \ud50c\ub7ab\ud3fc\uc758 \uc131\uc7a5<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc774\uc9c8\uc801\uc778 \uae00\ub85c\ubc8c \uaddc\uc81c \ud504\ub808\uc784\uc6cc\ud06c<\/li>\n<li class=\"toc-level-3\">4.3.2 \ub9de\ucda4\ud615 \ud30c\uc9c0\uc5d0 \ub300\ud55c \uc81c\ud55c\uc801\uc778 GMP \uc81c\uc870 \uc5ed\ub7c9<\/li>\n<li class=\"toc-level-3\">4.3.3 \ud30c\uc9c0 \ub0b4\uc131 \uc138\uade0 \ub3cc\uc5f0\ubcc0\uc774\uc758 \ucd9c\ud604<\/li>\n<li class=\"toc-level-3\">4.3.4 \ubd88\ud655\uc2e4\ud55c \uc0c1\ud658 \ubc0f \uc9c0\uc801 \uc7ac\uc0b0\uad8c \ubcf4\ud638 \ubaa8\ub378<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58-USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \ud30c\uc9c0 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc790\uc5f0 \uc6a9\uade0\uc131 \ud30c\uc9c0<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc720\uc804\uc790 \ubcc0\ud615 \/ \ud569\uc131 \ud30c\uc9c0<\/li>\n<li class=\"toc-level-3\">5.1.3 \ud30c\uc9c0 \uce75\ud14c\uc77c<\/li>\n<li class=\"toc-level-3\">5.1.4 \uc5d4\ub3c4\ub77c\uc774\uc2e0 &amp; \ud30c\uc9c0 \uc720\ub798 \ud6a8\uc18c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ud45c\uc801 \ubc15\ud14c\ub9ac\uc544\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ub300\uc7a5\uade0<\/li>\n<li class=\"toc-level-3\">5.2.2 \ud669\uc0c9\ud3ec\ub3c4\uc0c1\uad6c\uade0<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc5f0\uc1c4\uc0c1\uad6c\uade0<\/li>\n<li class=\"toc-level-3\">5.2.4 \ub179\ub18d\uade0<\/li>\n<li class=\"toc-level-3\">5.2.5 \uc0b4\ubaa8\ub12c\ub77c\uade0<\/li>\n<li class=\"toc-level-3\">5.2.6 \ud3d0\ub834\uac04\uade0<\/li>\n<li class=\"toc-level-3\">5.2.7 \uae30\ud0c0 \ubc15\ud14c\ub9ac\uc544<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ud22c\uc5ec \ubc29\uc2dd\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uacbd\uad6c<\/li>\n<li class=\"toc-level-3\">5.3.2 \uad6d\uc18c<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc8fc\uc0ac (\uc815\ub9e5\/\uadfc\uc721)<\/li>\n<li class=\"toc-level-3\">5.3.4 \ud761\uc785 \/ \ubd84\ubb34<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uac10\uc5fc\uc131 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.4.2 \ud56d\uade0\uc81c \ub0b4\uc131 \uc644\ud654<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc0dd\ubb3c\ub9c9 \uac10\uc5fc<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc218\uc758\ud559 \uc801\uc6a9<\/li>\n<li class=\"toc-level-3\">5.4.5 \uc591\uc2dd &amp; \ub18d\uc5c5<\/li>\n<li class=\"toc-level-3\">5.4.6 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c8\ubcd1 \uc801\uc751\uc99d\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uc694\ub85c \uac10\uc5fc<\/li>\n<li class=\"toc-level-3\">5.5.2 \ub9cc\uc131 \uc911\uc774\uc5fc<\/li>\n<li class=\"toc-level-3\">5.5.3 \uce58\uacfc &amp; \uad6c\uac15 \uac10\uc5fc<\/li>\n<li class=\"toc-level-3\">5.5.4 \ub9cc\uc131 \uada4\uc591\uc131 \ub300\uc7a5\uc5fc<\/li>\n<li class=\"toc-level-3\">5.5.5 \ubf08 &amp; \uad00\uc808 \uac10\uc5fc<\/li>\n<li class=\"toc-level-3\">5.5.6 \uc0c1\ucc98 &amp; \ud53c\ubd80 \uac10\uc5fc<\/li>\n<li class=\"toc-level-3\">5.5.7 \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d \ud3d0 \uac10\uc5fc<\/li>\n<li class=\"toc-level-3\">5.5.8 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc0ac\uc6a9 \uac00\ub2a5\ud55c \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Armata Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.2 BiomX<\/li>\n<li class=\"toc-level-3\">6.3.3 Eligo Bioscience<\/li>\n<li class=\"toc-level-3\">6.3.4 Intralytix<\/li>\n<li class=\"toc-level-3\">6.3.5 iNtODEWorld<\/li>\n<li class=\"toc-level-3\">6.3.6 Locus Biosciences<\/li>\n<li class=\"toc-level-3\">6.3.7 TechnoPhage<\/li>\n<li class=\"toc-level-3\">6.3.8 Eliava BioPreparations<\/li>\n<li class=\"toc-level-3\">6.3.9 Nextbiotics<\/li>\n<li class=\"toc-level-3\">6.3.10 PhagePro<\/li>\n<li class=\"toc-level-3\">6.3.11 Nexabiome<\/li>\n<li class=\"toc-level-3\">6.3.12 Adaptive Phage Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.13 Pherecydes Pharma<\/li>\n<li class=\"toc-level-3\">6.3.14 Enbiotix<\/li>\n<li class=\"toc-level-3\">6.3.15 Fixed Phage<\/li>\n<li class=\"toc-level-3\">6.3.16 Tailor Bio<\/li>\n<li class=\"toc-level-3\">6.3.17 Cellexus<\/li>\n<li class=\"toc-level-3\">6.3.18 ContraFect<\/li>\n<li class=\"toc-level-3\">6.3.19 APT Phage<\/li>\n<li class=\"toc-level-3\">6.3.20 Micreos<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8, \uc804\ub9dd, \ub3d9\ud5a5 \ubc0f \uae00\ub85c\ubc8c \ubcf4\uace0\uc11c 2031 \uc694\uc57d<\/p>\n<p># 1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc218\uce58<\/p>\n<p>\ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc740 2026\ub144 12\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 15\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 3.72%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uafb8\uc900\ud55c \uc131\uc7a5\uc740 \ud56d\uc0dd\uc81c \ub0b4\uc131(Antimicrobial Resistance, AMR) \ubb38\uc81c \uc2ec\ud654\uc640 \uc0dd\uccb4 \uce58\ub8cc\uc81c(live biotherapeutic products)\uc5d0 \ub300\ud55c \uaddc\uc81c \uacbd\ub85c\uac00 \uba85\ud655\ud574\uc9d0\uc5d0 \ub530\ub77c \ud30c\uc9c0 \uce58\ub8cc\uac00 \uc2e4\ud5d8\uc801 \ub2e8\uacc4\ub97c \ub118\uc5b4 \uc77c\uc0c1\uc801\uc778 \uc784\uc0c1 \uce58\ub8cc\ub85c \uc804\ud658\ub418\uace0 \uc788\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>\ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d, \ub2f9\ub1e8\ubcd1\uc131 \uc871\ubd80 \uace8\uc218\uc5fc, \ub09c\uce58\uc131 \uc694\ub85c \uac10\uc5fc \ub4f1\uc5d0\uc11c \ud30c\uc9c0 \uce58\ub8cc\uc758 \uce58\ub8cc\uc801 \uac00\uce58\uac00 \uc785\uc99d\ub418\uba74\uc11c \ud22c\uc790\uac00 \ud65c\uc131\ud654\ub418\uace0 \uc788\uc73c\uba70, \ubca8\uae30\uc5d0, \ud55c\uad6d, \ubbf8\uad6d \ub4f1\uc9c0\uc5d0 \ubaa9\uc801\uc5d0 \ub9de\ub294 GMP(Good Manufacturing Practice) \uc0dd\uc0b0 \uc2dc\uc124\uc774 \uad6c\ucd95\ub418\uc5b4 \uc0dd\uc0b0 \uaddc\ubaa8 \ud655\ub300\uc5d0 \uc9c4\uc804\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \ud569\uc131 \uc0dd\ubb3c\ud559 \ud50c\ub7ab\ud3fc\uc740 \ud30c\uc9c0 \ubc1c\uacac \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \ubc15\ud14c\ub9ac\uc544 \uc801\uc6a9 \ubc94\uc704\ub97c \ub113\ud788\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 3\uc6d4 BiomX\uac00 Adaptive Phage Therapeutics\ub97c 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc778\uc218\ud558\uba70 \uc2e0\uaddc \uc790\ubcf8\uc744 \ud655\ubcf4\ud55c \uc0ac\ub840\ub294 \ud22c\uc790\uc790\ub4e4\uc758 \uc9c0\uc18d\uc801\uc778 \uc2e0\ub8b0\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc804\ubc18\uc801\uc73c\ub85c \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc740 \ud655\uc7a5\ub418\uba74\uc11c\ub3c4 \uaddc\uc728 \uc788\ub294 \uc131\uc7a5 \uada4\ub3c4\ub97c \uad6c\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc9c0\ud45c:<br \/>\n*   \uc5f0\uad6c \uae30\uac04: 2020\ub144 &#8211; 2031\ub144<br \/>\n*   2026\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 12\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   2031\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 15\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2026-2031): 3.72% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<\/p>\n<p># 2. \uc2dc\uc7a5 \uc138\ubd84\ud654 \ubd84\uc11d<\/p>\n<p>2.1. \ud30c\uc9c0 \uc720\ud615\ubcc4:<br \/>\n2025\ub144 \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \ud30c\uc9c0 \uce75\ud14c\uc77c(Phage Cocktails)\uc774 35.78%\uc758 \uc810\uc720\uc728\ub85c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc5ec\ub7ec \ubc15\ud14c\ub9ac\uc544 \uc218\uc6a9\uccb4\ub97c \ucee4\ubc84\ud558\uace0 \ub0b4\uc131 \ubc1c\ud604\uc744 \uc5b5\uc81c\ud558\ub294 \ud63c\ud569 \uc81c\uc81c\uc5d0 \ub300\ud55c \uc784\uc0c1\uc801 \uc120\ud638\ub97c \ubc18\uc601\ud569\ub2c8\ub2e4. \ucc9c\uc5f0 \uc6a9\uade0\uc131 \ud30c\uc9c0(Natural Lytic Phages)\ub294 \uae34\uae09 \uc0c1\ud669\uc5d0\uc11c \uacc4\uc18d \uc0ac\uc6a9\ub418\uba70, \uc5d4\ub3cc\ub9ac\uc2e0(Endolysins) \ubc0f \uae30\ud0c0 \ud30c\uc9c0 \uc720\ub798 \ud6a8\uc18c\ub294 \ud608\ub958 \uac10\uc5fc \uce58\ub8cc\uc81c \uc5d1\uc138\ubc14\uce74\uc81c(exebacase)\uc640 \uac19\uc740 \ud6c4\uae30 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \ud1b5\ud574 \ubc1c\uc804\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uc720\uc804 \uacf5\ud559 \ud569\uc131 \ud30c\uc9c0(Genetically Engineered Synthetic Phages)\ub294 2031\ub144\uae4c\uc9c0 7.35%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. CRISPR \ud398\uc774\ub85c\ub4dc(payloads)\ub97c \ud1b5\ud574 \ud504\ub85c\uadf8\ub798\ubc0d \uac00\ub2a5\ud55c \uc720\uc804\uccb4 \ubd84\ud574\ub97c \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \ud2b9\uc774\uc131\uc744 \uc720\uc9c0\ud558\uba74\uc11c \uc219\uc8fc \ubc94\uc704\ub97c \ub113\ud788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4.<\/p>\n<p>2.2. \ud45c\uc801 \ubc15\ud14c\ub9ac\uc544\ubcc4:<br \/>\n2025\ub144 \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \ub179\ub18d\uade0(Pseudomonas aeruginosa) \uac10\uc5fc\uc774 26.88%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc810\uc720\uc728\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d, \uc778\uacf5\ud638\ud761\uae30 \uad00\ub828 \ud3d0\ub834, \ub9cc\uc131 \uc0c1\ucc98 \ub4f1\uc5d0\uc11c\uc758 \ub192\uc740 \uc720\ubcd1\ub960\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. NIH\ub294 ESKAPE \ubcd1\uc6d0\uccb4\uc5d0 \ub300\ud55c \uc790\uae08 \uc9c0\uc6d0\uc744 \uc6b0\uc120\uc2dc\ud558\uba70, \ub179\ub18d\uade0\uc5d0 \ucd08\uc810\uc744 \ub9de\ucd98 \uce75\ud14c\uc77c \uc81c\uc81c\uac00 \uc784\uc0c1 \ubd84\ub9ac\uc8fc\uc758 96%\ub97c \uc911\ud654\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uce74\ubc14\ud398\ub134 \ub0b4\uc131\uade0\uc774 \uc911\ud658\uc790\uc2e4\uc5d0\uc11c \uae09\uc99d\ud568\uc5d0 \ub530\ub77c \ud3d0\ub834\uac04\uade0(Klebsiella pneumoniae)\uc740 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 6.02%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ud669\uc0c9\ud3ec\ub3c4\uc0c1\uad6c\uade0(Staphylococcus aureus)\uc740 \uc778\uacf5 \uad00\uc808 \ubc0f \uace8\uc218\uc5fc \ud504\ub85c\uadf8\ub7a8\uc5d0\uc11c, \ub300\uc7a5\uade0(Escherichia coli)\uc740 \uc7ac\ubc1c\uc131 \uc694\ub85c \uac10\uc5fc \uce58\ub8cc\uc5d0\uc11c \uc911\uc694\ud55c \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2.3. \ud22c\uc5ec \ubc29\uc2dd\ubcc4:<br \/>\n2025\ub144 \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \uc8fc\uc0ac\uc81c(Injectables)\uac00 44.63%\uc758 \uc810\uc720\uc728\ub85c \uc6b0\uc704\ub97c \uc810\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uade0\ud608\uc99d \ubc0f \uc2ec\ub0b4\ub9c9\uc5fc\uacfc \uac19\uc740 \uc804\uc2e0 \uac10\uc5fc\uc774 \uc2e0\uc18d\ud55c \uc57d\ubb3c \ub178\ucd9c\uc744 \ud544\uc694\ub85c \ud558\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uc815\ub9e5 \uc8fc\uc0ac \uc81c\uc81c\ub294 \ud30c\uc9c0 \uce75\ud14c\uc77c\uacfc \uc800\uc6a9\ub7c9 \ud56d\uc0dd\uc81c\ub97c \ubcd1\uc6a9\ud558\uc5ec \uc2dc\ub108\uc9c0 \ud6a8\uacfc\ub97c \ub192\uc774\uace0 \ub0b4\uc131 \ubc1c\ud604\uc744 \uc9c0\uc5f0\uc2dc\ud0a4\ub294 \ub370 \ud65c\uc6a9\ub429\ub2c8\ub2e4. \ud761\uc785 \ud22c\uc5ec(Inhalation)\ub294 6.18%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d \ud504\ub85c\uadf8\ub7a8\uc5d0\uc11c \ubd84\ubb34\ud615 BX004\uac00 \ud3d0 \ub3c5\uc131 \uc5c6\uc774 \uc138\uade0 \ubd80\ud558\ub97c \uac10\uc18c\uc2dc\ud0a8 \uac83\uc774 \uc8fc\uc694 \uc6d0\uc778\uc785\ub2c8\ub2e4. \uad6d\uc18c \uc2a4\ud504\ub808\uc774(Topical sprays) \ubc0f \uacbd\uad6c \ubbf8\uc138 \ucea1\uc290\ud654(Oral micro-encapsulation) \uc81c\uc81c\ub3c4 \uac1c\ubc1c \uc911\uc774\uba70, \uc774\ub294 \ub2e4\uc591\ud55c \uce58\ub8cc \ud658\uacbd\uc5d0\uc11c \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ud655\ub300\ud558\ub294 \ub370 \uae30\uc5ec\ud569\ub2c8\ub2e4.<\/p>\n<p>2.4. \uc801\uc6a9 \ubd84\uc57c\ubcc4:<br \/>\n2025\ub144 \uac10\uc5fc\uc131 \uc9c8\ud658(Infectious Diseases)\uc774 51.93%\uc758 \ub9e4\ucd9c \uc810\uc720\uc728\ub85c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ud56d\uc0dd\uc81c\uac00 \ud6a8\uacfc\uc801\uc774\uc9c0 \uc54a\uc740 \uae09\uc131 \ubc0f \ub9cc\uc131 \uc138\uade0 \uac10\uc5fc\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \uc758\uc0ac\ub4e4\uc740 \ube44\uce58\uc720\uc131 \uc0c1\ucc98\uc758 \ubcc0\uc5f0 \uc808\uc81c\uc220\uacfc \uc778\uacf5 \uad00\uc808 \ubcf4\uc874\uc220\uc758 \ubcf4\uc870\uc81c\ub85c \ud30c\uc9c0 \uce75\ud14c\uc77c\uc744 \ucc98\ubc29\ud558\uc5ec \uc0ac\uc9c0 \ubcf4\uc874\uc728\uc744 \ud5a5\uc0c1\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud56d\uc0dd\uc81c \ub0b4\uc131 \uc644\ud654(Antibacterial Resistance Mitigation)\ub294 2031\ub144\uae4c\uc9c0 7.02%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud30c\uc9c0 \ubc0f \uc5d4\ub3cc\ub9ac\uc2e0\uc774 \uc18c\ubd84\uc790 \uc57d\ubb3c\ub85c\ub294 \ub3c4\ub2ec\ud558\uae30 \uc5b4\ub824\uc6b4 \uc138\ud3ec\uc678 \uae30\uc9c8(extracellular matrices)\uc5d0 \uce68\ud22c\ud558\uc5ec \uc0dd\ubb3c\ub9c9(biofilm)\uc744 \ud30c\uad34\ud558\ub294 \uac83\uc774 \uc911\uc694\ud558\uac8c \uc791\uc6a9\ud569\ub2c8\ub2e4. \uc218\uc758\ud559, \uc591\uc2dd\uc5c5, \uc791\ubb3c \ubcf4\ud638 \ubd84\uc57c\uc5d0\uc11c\uc758 \uc801\uc6a9\uc740 \ub18d\uc5c5\uc6a9 \ud56d\uc0dd\uc81c \uc0ac\uc6a9\uc744 \uc904\uc774\uace0 &#8216;\ud558\ub098\uc758 \uac74\uac15(One-Health)&#8217; \ubaa9\ud45c\uc640 \uc5f0\uacc4\ub429\ub2c8\ub2e4.<\/p>\n<p>2.5. \uc9c8\ubcd1 \uc801\uc751\uc99d\ubcc4:<br \/>\n2025\ub144 \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d \ud3d0 \uac10\uc5fc(Cystic Fibrosis Lung Infections)\uc774 26.31%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud588\uc73c\uba70, 2031\ub144\uae4c\uc9c0 6.05%\uc758 \uc131\uc7a5\ub960\uc744 \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ub9cc\uc131 \ub179\ub18d\uade0 \uc9d1\ub77d\ud654\uac00 \uc8fc\uc694 \uc774\ud658\uc728 \uc6d0\uc778\uc774\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ub2e4\uc81c\ub0b4\uc131 \ub300\uc7a5\uade0\uc744 \ud45c\uc801\uc73c\ub85c \ud558\ub294 ELIMINATE Phase 2 \ud504\ub85c\uadf8\ub7a8\uc5d0 \ud798\uc785\uc5b4 \uc694\ub85c \uac10\uc5fc(Urinary Tract Infections)\uc774 \uadf8 \ub4a4\ub97c \uc787\uc2b5\ub2c8\ub2e4. \uace8 \ubc0f \uad00\uc808 \uac10\uc5fc, \ud2b9\ud788 \uc778\uacf5 \uad00\uc808 \uac10\uc5fc\uc740 \uc0dd\ubb3c\ub9c9\uc744 \uc81c\uac70\ud558\uba74\uc11c \uc784\ud50c\ub780\ud2b8\ub97c \ubcf4\uc874\ud558\ub294 \uad00\uc808 \ub0b4 \ud30c\uc9c0 \uc800\uc7a5\uc18c(intra-articular phage depots)\ub97c \ud65c\uc6a9\ud569\ub2c8\ub2e4. \ub9cc\uc131 \uc911\uc774\uc5fc \ubc0f \uce58\uacfc \ubd84\uc57c\uc5d0\uc11c\ub3c4 \ubcd1\uc6d0\uccb4 \ud2b9\uc774\uc131\uc744 \ud1b5\ud574 \uacf5\uc0dd \ubbf8\uc0dd\ubb3c\ucd1d\uc744 \ubcf4\uc874\ud558\uc5ec \uc774\uc9c8\uc99d(dysbiosis) \ud569\ubcd1\uc99d\uc744 \uc904\uc774\ub294 \uc774\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p># 3. \uc2dc\uc7a5 \ub3d9\uc778 \ubc0f \uc81c\uc57d \uc694\uc778<\/p>\n<p>3.1. \uc8fc\uc694 \ub3d9\uc778:<br \/>\n*   \ub2e4\uc81c\ub0b4\uc131 \uac10\uc5fc\uc758 \uc99d\uac00: 2024\ub144 \uac10\uc2dc \ub370\uc774\ud130\ub294 \uc774\uc9d1\ud2b8 \uc18c\uc640 \uc778\uac04\uc5d0\uc11c \uc0b4\ubaa8\ub12c\ub77c \uc5d4\ud14c\ub9ac\uce74(Salmonella enterica)\uc758 \ub192\uc740 \ub0b4\uc131\uc744 \ubcf4\uc5ec\uc8fc\uba70 \ub300\uccb4 \uce58\ub8cc\ubc95\uc758 \uc2dc\uae09\uc131\uc744 \ubd80\uac01\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \ubcd1\uc6d0\ub4e4\uc740 ESKAPE \ubcd1\uc6d0\uccb4\uc5d0 \ub300\ud55c \ud30c\uc9c0 \uce58\ub8cc\ub97c \ud544\uc218\uc801\uc778 \ub3c4\uad6c\ub85c \uac04\uc8fc\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. (CAGR \uc601\ud5a5: +1.2%)<br \/>\n*   \uc784\uc0c1 \ub2e8\uacc4 \ud30c\uc774\ud504\ub77c\uc778 \ubc0f \uc790\uae08 \uc870\ub2ec \ud655\ub300: BiomX\uc758 Adaptive Phage Therapeutics \uc778\uc218(5\ucc9c\ub9cc \ub2ec\ub7ec)\uc640 BARDA\uc758 Locus Biosciences\uc5d0 \ub300\ud55c 2,390\ub9cc \ub2ec\ub7ec \uc9c0\uc6d0\uc740 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. (CAGR \uc601\ud5a5: +0.8%)<br \/>\n*   \uad6d\uac00 \ud30c\uc9c0 \uc740\ud589 \ubc0f \ub3d9\uc815\uc801 \uc0ac\uc6a9 \ub124\ud2b8\uc6cc\ud06c \uad6c\ucd95: \ubca8\uae30\uc5d0\uc758 \uc870\uc81c \uc2dc\uc2a4\ud15c, \uc774\uc2a4\ub77c\uc5d8 \ud30c\uc9c0 \uce58\ub8cc \uc13c\ud130\uc758 \uae0d\uc815\uc801 \uacb0\uacfc, \uc601\uad6d \uc2dc\ubbfc \ud30c\uc9c0 \ub77c\uc774\ube0c\ub7ec\ub9ac\uc758 \uc2e0\uc18d\ud55c \ud30c\uc9c0 \ubd84\ub9ac \ub2a5\ub825 \ub4f1\uc740 \ud30c\uc9c0 \uce58\ub8cc \uc811\uadfc\uc131\uc744 \ub192\uc785\ub2c8\ub2e4. (CAGR \uc601\ud5a5: +0.6%)<br \/>\n*   \ud569\uc131 \uc0dd\ubb3c\ud559 \uae30\ubc18\uc758 \ub9de\ucda4\ud615 \ud30c\uc9c0 \uc784\uc0c1 \uc2dc\ud5d8 \uc9c4\uc785: Locus Biosciences\uc758 CRISPR-Cas3 \uae30\uc220\uacfc Northwestern University\uc758 \ub179\ub18d\uade0 \uc790\uac00 \ud30c\uad34 \uc720\ub3c4 \ud30c\uc9c0 \uac1c\ubc1c \ub4f1\uc740 \ud601\uc2e0\uc744 \uac00\uc838\uc635\ub2c8\ub2e4. (CAGR \uc601\ud5a5: +0.9%)<br \/>\n*   \ud30c\uc9c0 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \uc2e0\uc18d \uc2ec\uc0ac \uc9c0\uc815: \ubd81\ubbf8 \ubc0f \uc720\ub7fd\uc5d0\uc11c \uaddc\uc81c \ub2f9\uad6d\uc758 \uc2e0\uc18d \uc2ec\uc0ac \uc9c0\uc815\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. (CAGR \uc601\ud5a5: +0.5%)<br \/>\n*   \uc815\ubc00 \ub9c8\uc774\ud06c\ub85c\ubc14\uc774\uc634 \uc758\ud559 \ud50c\ub7ab\ud3fc\uc758 \uc131\uc7a5: \ub9c8\uc774\ud06c\ub85c\ubc14\uc774\uc634 \uc758\ud559\uc758 \ubc1c\uc804\uc740 \ud30c\uc9c0 \uce58\ub8cc\uc758 \uc0c8\ub85c\uc6b4 \uc801\uc6a9 \uac00\ub2a5\uc131\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4. (CAGR \uc601\ud5a5: +0.7%)<\/p>\n<p>3.2. \uc8fc\uc694 \uc81c\uc57d \uc694\uc778:<br \/>\n*   \uc774\uc9c8\uc801\uc778 \uae00\ub85c\ubc8c \uaddc\uc81c \ud504\ub808\uc784\uc6cc\ud06c: \ubca8\uae30\uc5d0\ub294 \uc870\uc81c\ub97c \ud5c8\uc6a9\ud558\uc9c0\ub9cc, \ub9ce\uc740 EU \ud68c\uc6d0\uad6d\uc740 \ud30c\uc9c0\ub97c \ucca8\ub2e8 \uce58\ub8cc \uc758\uc57d\ud488\uc73c\ub85c \ucde8\uae09\ud558\uc5ec \ubcc4\ub3c4\uc758 \uc11c\ub958\ub97c \uc694\uad6c\ud558\ub294 \ub4f1 \uaddc\uc81c \ubd88\uc77c\uce58\ub294 \uac1c\ubc1c \ube44\uc6a9\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4. (CAGR \uc601\ud5a5: -0.7%)<br \/>\n*   \uac1c\uc778 \ub9de\ucda4\ud615 \ud30c\uc9c0\ub97c \uc704\ud55c GMP \uc81c\uc870 \uc5ed\ub7c9 \ubd80\uc871: \uc804\ud1b5\uc801\uc778 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uacf5\uc7a5\uc740 \ub300\uaddc\ubaa8 \uade0\uc77c \ubc30\uce58\uc5d0 \uc801\ud569\ud558\uba70, \uc2e0\uc18d\ud558\uace0 \ud658\uc790 \ub9de\ucda4\ud615 \uc0dd\uc0b0\uc5d0\ub294 \ud55c\uacc4\uac00 \uc788\uc5b4 \uacf5\uae09 \uc9c0\uc5f0\uc744 \ucd08\ub798\ud569\ub2c8\ub2e4. (CAGR \uc601\ud5a5: -0.9%)<br \/>\n*   \ud30c\uc9c0 \ub0b4\uc131 \uc138\uade0 \ub3cc\uc5f0\ubcc0\uc774\uc758 \ucd9c\ud604: \ubc15\ud14c\ub9ac\uc544\uc758 \ud30c\uc9c0 \ub0b4\uc131 \ubc1c\ud604\uc740 \uc7a5\uae30\uc801\uc778 \uce58\ub8cc \ud6a8\uacfc\uc5d0 \ub300\ud55c \uc6b0\ub824\ub97c \ub0b3\uc2b5\ub2c8\ub2e4. (CAGR \uc601\ud5a5: -0.6%)<br \/>\n*   \ubd88\ud655\uc2e4\ud55c \uc0c1\ud658 \ubc0f \uc9c0\uc801 \uc7ac\uc0b0\uad8c \ubaa8\ub378: \ubd81\ubbf8 \ubc0f \uc720\ub7fd\uc5d0\uc11c \ud30c\uc9c0 \uce58\ub8cc\uc5d0 \ub300\ud55c \uc0c1\ud658 \uc815\ucc45\uacfc \uc9c0\uc801 \uc7ac\uc0b0\uad8c \ubaa8\ub378\uc758 \ubd88\ud655\uc2e4\uc131\uc740 \ud22c\uc790 \ubc0f \uc0c1\uc5c5\ud654\ub97c \uc800\ud574\ud569\ub2c8\ub2e4. (CAGR \uc601\ud5a5: -0.8%)<\/p>\n<p># 4. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c 33.85%\uc758 \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. FDA\uc758 \uae34\uae09 \ud504\ub85c\uadf8\ub7a8\uacfc BARDA, CARB-X\uc640 \uac19\uc740 \uc5f0\ubc29 \ubcf4\uc870\uae08\uc740 \uc5f0\uad6c \uacb0\uacfc\ub97c \uc784\uc0c1\uc5d0 \uc801\uc6a9\ud558\ub294 \uacfc\uc815\uc744 \uac04\uc18c\ud654\ud569\ub2c8\ub2e4. UC \uc0cc\ub514\uc5d0\uc774\uace0\uc758 IPATH\uc640 \uac19\uc740 \uc13c\ud130\ub294 \uc784\uc0c1\uc758\uac00 \uba70\uce60 \ub0b4\uc5d0 \uc811\uadfc\ud560 \uc218 \uc788\ub294 \ud050\ub808\uc774\uc158\ub41c \ud30c\uc9c0 \ub77c\uc774\ube0c\ub7ec\ub9ac\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: 2023\ub144 EMA \uac00\uc774\ub4dc\ub77c\uc778\uc740 \ud488\uc9c8 \ubc0f \uc784\uc0c1 \uae30\ub300\uce58\ub97c \uc870\ud654\uc2dc\ucf1c \ubca8\uae30\uc5d0, \ud504\ub791\uc2a4, \ub3c5\uc77c \uc804\ubc18\uc758 \ud22c\uc790\ub97c \uc9c0\uc6d0\ud569\ub2c8\ub2e4. \ubca8\uae30\uc5d0\uc758 \uc870\uc81c \uc2dc\uc2a4\ud15c\uc740 \uac1c\uc778 \ub9de\ucda4\ud615 \uacf5\uae09\uc744 \uac00\uc18d\ud654\ud558\uba70, \uc601\uad6d \uc2dc\ubbfc \ud30c\uc9c0 \ub77c\uc774\ube0c\ub7ec\ub9ac\ub294 \uc2e0\uc18d \ub300\uc751 \ub2a5\ub825\uc744 \uac15\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 6.6%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d\uc758 \ud65c\ubc1c\ud55c \uc5f0\uad6c \ubc1c\ud45c\ub294 \uc0c8\ub85c\uc6b4 \ubc14\uc774\uc624 \uc0dd\uc0b0 \uc2dc\uc124\uacfc \uc5f0\uacc4\ub418\uba70, \uc77c\ubcf8\uc740 \uc7ac\uc0dd \uc758\ud559 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \ud65c\uc6a9\ud558\uace0, \ud55c\uad6d\uc758 \ud654\uc131 \uacf5\uc7a5\uc740 GMP \uc0dd\uc0b0 \uc5ed\ub7c9\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc778\ub3c4\ub294 \ub3d9\uc815\uc801 \uc0ac\uc6a9 \uc9c0\uce68\uc744 \ub9c8\ub828 \uc911\uc774\uba70, \ud638\uc8fc\ub294 \uac15\ub825\ud55c \uc784\uc0c1 \uc2dc\ud5d8 \uc778\ud504\ub77c\ub97c \uad6c\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 5. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. BiomX, Armata Pharmaceuticals, Locus Biosciences\uac00 \ud6c4\uae30 \ub2e8\uacc4 \ud30c\uc774\ud504\ub77c\uc778\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. BiomX\ub294 Adaptive Phage Therapeutics \uc778\uc218\ub97c \ud1b5\ud574 \ub3c5\uc810\uc801\uc778 \ub9e4\uce6d \uc54c\uace0\ub9ac\uc998\uacfc 2,400\uac1c \uade0\uc8fc \uceec\ub809\uc158\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. Locus Biosciences\ub294 CRISPR-Cas3 \uae30\uc220\uacfc BARDA\uc758 \uc9c0\uc6d0\uc744 \ubc1b\uace0 \uc788\uc73c\uba70, Armata\ub294 \ud638\ud761\uae30 \uac10\uc5fc\uc744 \uc704\ud55c \ud761\uc785\ud615 \ud30c\uc9c0 \uce58\ub8cc\uc81c\uc5d0 \uc9d1\uc911\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc9c4\uc785 \uc7a5\ubcbd\uc73c\ub85c\ub294 \ud050\ub808\uc774\uc158\ub41c \uade0\uc8fc \ub77c\uc774\ube0c\ub7ec\ub9ac, GMP \uc900\uc218, \ubcf5\uc7a1\ud55c \uaddc\uc81c \uc808\ucc28 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc18c\uc544\uacfc \uc0ac\uc6a9, \uc2e0\uc18d \uc9c4\ub2e8, \ud56d\uc0dd\uc81c-\ud30c\uc9c0 \ubcd1\uc6a9 \uc81c\uc81c \ub4f1\uc5d0\uc11c \uae30\ud68c\uac00 \uc5ec\uc804\ud788 \uc874\uc7ac\ud569\ub2c8\ub2e4. AI \uae30\ubc18 \ub9e4\uce6d \ubc0f \ud569\uc131 \uc2a4\uce90\ud3f4\ub4dc(synthetic scaffolds)\ub97c \ud0d0\uad6c\ud558\ub294 \ud559\uc220 \uc2a4\ud540\uc624\ud504 \uae30\uc5c5\ub4e4\uc740 \uae30\uc874 \ubaa8\ub378\uc744 \ud601\uc2e0\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. 2025\ub144 PHAXIAM Therapeutics\uac00 \ud30c\uc0b0 \uad00\uc7ac\uc778 \uad00\ub9ac\uc5d0 \ub4e4\uc5b4\uac04 \uc0ac\ub840\uc5d0\uc11c \ubcfc \uc218 \uc788\ub4ef\uc774 \uc7ac\uc815\uc801 \uc704\ud5d8\uc740 \uc5ec\uc804\ud788 \uc874\uc7ac\ud569\ub2c8\ub2e4. \ub530\ub77c\uc11c \ud559\uacc4, \uc815\ubd80, \uc0b0\uc5c5 \uac04\uc758 \uc804\ub7b5\uc801 \uc81c\ud734\ub294 \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc744 \uc720\uc9c0\ud558\ub294 \ub370 \ub9e4\uc6b0 \uc911\uc694\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790:<br \/>\n*   Armata Pharmaceuticals<br \/>\n*   Locus Biosciences<br \/>\n*   BiomX<br \/>\n*   Intralytix<br \/>\n*   Adaptive Phage Therapeutics<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5:<br \/>\n*   2025\ub144 4\uc6d4: BiomX\ub294 \ub2f9\ub1e8\ubcd1\uc131 \uc871\ubd80 \uace8\uc218\uc5fc \uce58\ub8cc\uc81c BX211\uc758 \uae0d\uc815\uc801\uc778 2\uc0c1 \uc784\uc0c1\uc2dc\ud5d8 \uacb0\uacfc\ub97c \ubc1c\ud45c\ud558\uba70 \uc548\uc804\uc131\uacfc \uc784\uc0c1\uc801 \uc774\uc810\uc744 \ud655\uc778\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 3\uc6d4: BiomX\ub294 Adaptive Phage Therapeutics\ub97c 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc778\uc218\ud558\uc5ec 2\uc0c1 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \ud655\uc7a5\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 1\uc6d4: Locus Biosciences\ub294 BARDA\ub85c\ubd80\ud130 2,390\ub9cc \ub2ec\ub7ec\ub97c \ud655\ubcf4\ud558\uc5ec \uc57d\ubb3c \ub0b4\uc131 \ub300\uc7a5\uade0 \uc694\ub85c \uac10\uc5fc \uce58\ub8cc\uc81c CRISPR-\uc5d4\uc9c0\ub2c8\uc5b4\ub9c1 LBP-EC01 \uac1c\ubc1c\uc744 \uac00\uc18d\ud654\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \ubc15\ud14c\ub9ac\uc544 \uac10\uc5fc \uce58\ub8cc\uc5d0 \ubc15\ud14c\ub9ac\uc624\ud30c\uc9c0\ub97c \ud65c\uc6a9\ud558\ub294 \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ud30c\uc9c0 \uce58\ub8cc\ub294 \uc720\ud574 \ubc15\ud14c\ub9ac\uc544\ub97c \uc815\ud655\ud558\uac8c \ud45c\uc801\ud654\ud558\uace0 \uc81c\uac70\ud558\uc5ec \uae30\uc874 \ud56d\uc0dd\uc81c\uc758 \uc720\ub9dd\ud55c \ub300\uc548\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc73c\uba70, \uc720\uc775\ud55c \ubc15\ud14c\ub9ac\uc544\ub97c \ubcf4\ud638\ud558\uace0 \uc7a0\uc7ac\uc801 \ubd80\uc791\uc6a9\uc744 \uc904\uc774\ub294 \uc7a5\uc810\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \ub2e4\uc81c\ub0b4\uc131(MDR) \uac10\uc5fc\uc758 \ud655\uc0b0 \uc99d\uac00, \uc784\uc0c1 \ub2e8\uacc4 \ud30c\uc9c0 \ud30c\uc774\ud504\ub77c\uc778 \ubc0f \uc790\uae08 \uc870\ub2ec \ub77c\uc6b4\ub4dc\uc758 \ud655\ub300, \uad6d\uac00 \ud30c\uc9c0 \uc740\ud589 \ubc0f \ub3d9\uc815\uc801 \uc0ac\uc6a9 \ub124\ud2b8\uc6cc\ud06c\uc758 \uad6c\ucd95\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \ud569\uc131 \uc0dd\ubb3c\ud559 \uae30\ubc18\uc758 &#8220;\ub514\uc790\uc774\ub108&#8221; \ud30c\uc9c0 \uc784\uc0c1 \uc2dc\ud5d8 \uc9c4\uc785, \ud30c\uc9c0 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \uc2e0\uc18d \uc2ec\uc0ac \uc9c0\uc815, \uc815\ubc00 \ub9c8\uc774\ud06c\ub85c\ubc14\uc774\uc634 \uc758\ud559 \ud50c\ub7ab\ud3fc\uc758 \uc131\uc7a5\uc774 \uc2dc\uc7a5 \ubc1c\uc804\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc18\uba74, \uc2dc\uc7a5\uc758 \uc81c\uc57d \uc694\uc778\uc73c\ub85c\ub294 \uc774\uc9c8\uc801\uc778 \uae00\ub85c\ubc8c \uaddc\uc81c \ud504\ub808\uc784\uc6cc\ud06c, \ub9de\ucda4\ud615 \ud30c\uc9c0\ub97c \uc704\ud55c \uc81c\ud55c\uc801\uc778 GMP \uc81c\uc870 \uc5ed\ub7c9, \ud30c\uc9c0 \ub0b4\uc131 \ubc15\ud14c\ub9ac\uc544 \ub3cc\uc5f0\ubcc0\uc774\uc758 \ucd9c\ud604, \ubd88\ud655\uc2e4\ud55c \uc0c1\ud658 \ubc0f \uc9c0\uc801 \uc7ac\uc0b0\uad8c \ubcf4\ud638 \ubaa8\ub378 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \ud30c\uc9c0 \uc720\ud615(\uc790\uc5f0 \uc6a9\uade0\uc131 \ud30c\uc9c0, \uc720\uc804\uc790 \uc870\uc791\/\ud569\uc131 \ud30c\uc9c0, \ud30c\uc9c0 \uce75\ud14c\uc77c, \uc5d4\ub3cc\ub9ac\uc2e0 \ubc0f \ud30c\uc9c0 \uc720\ub798 \ud6a8\uc18c), \ud45c\uc801 \ubc15\ud14c\ub9ac\uc544(\ub300\uc7a5\uade0, \ud669\uc0c9\ud3ec\ub3c4\uc0c1\uad6c\uade0, \uc5f0\uc1c4\uc0c1\uad6c\uade0, \ub179\ub18d\uade0, \uc0b4\ubaa8\ub12c\ub77c\uade0, \ud3d0\ub834\uac04\uade0 \ub4f1), \ud22c\uc5ec \uacbd\ub85c(\uacbd\uad6c, \uad6d\uc18c, \uc8fc\uc0ac, \ud761\uc785\/\ubd84\ubb34), \uc801\uc6a9 \ubd84\uc57c(\uac10\uc5fc\uc131 \uc9c8\ud658, \ud56d\uc0dd\uc81c \ub0b4\uc131 \uc644\ud654, \uc0dd\ubb3c\ub9c9 \uac10\uc5fc, \uc218\uc758\ud559, \uc591\uc2dd \ubc0f \ub18d\uc5c5 \ub4f1), \uc9c8\ubcd1 \uc801\uc751\uc99d(\uc694\ub85c \uac10\uc5fc, \ub9cc\uc131 \uc911\uc774\uc5fc, \uce58\uacfc \ubc0f \uad6c\uac15 \uac10\uc5fc, \ub9cc\uc131 \uada4\uc591\uc131 \ub300\uc7a5\uc5fc, \uace8\uad00\uc808 \uac10\uc5fc, \uc0c1\ucc98 \ubc0f \ud53c\ubd80 \uac10\uc5fc, \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d \ud3d0 \uac10\uc5fc \ub4f1), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5\uc740 2026\ub144 12\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 15\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5\uc73c\ub85c\ub294 2025\ub144 \uae30\uc900 \ub179\ub18d\uade0\uc774 \ud30c\uc9c0 \uce58\ub8cc \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 26.88%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \ud45c\uc801 \ubc15\ud14c\ub9ac\uc544\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \ud30c\uc9c0 \uce75\ud14c\uc77c\uc740 \ub354 \ub113\uc740 \uc219\uc8fc \ubc94\uc704\uc640 \ub0b4\uc131 \uac10\uc18c \ud6a8\uacfc\ub85c \uc778\ud574 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 35.78%\ub97c \uae30\ub85d\ud558\uba70 \ub2e8\uc77c \ud30c\uc9c0 \uc81c\uc81c\ubcf4\ub2e4 \uc120\ud638\ub429\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uc81c\uc870 \uc5ed\ub7c9 \ubc0f \uaddc\uc81c \uba85\ud655\uc131 \uac1c\uc120\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 6.6%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud22c\uc5ec \uacbd\ub85c \uc911\uc5d0\uc11c\ub294 \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d \ud504\ub85c\uadf8\ub7a8\uc5d0\uc11c \ubd84\ubb34\ud615 \ud30c\uc9c0 \uc81c\uc81c\uc758 \uc548\uc804\uc131\uacfc \ud6a8\ub2a5\uc774 \uc785\uc99d\ub428\uc5d0 \ub530\ub77c \ud761\uc785 \ud22c\uc5ec\uac00 \uc5f0\ud3c9\uade0 6.18%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \ubc1c\uc804\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d \ubc0f Armata Pharmaceuticals, BiomX, Intralytix \ub4f1 \uc8fc\uc694 \uae30\uc5c5 \ud504\ub85c\ud544\uc744 \ud3ec\ud568\ud558\uba70, \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc5d0 \ub300\ud55c \ud3c9\uac00\ub3c4 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-43317","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/43317"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=43317"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/43317\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=43317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=43317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=43317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}